| Author | Matos, Bruno Moisés de | |
| Author | Robert, Anny Waloski | |
| Author | Stimamiglio, Marco Augusto | |
| Author | Correa, Alejandro | |
| Access date | 2021-11-09T13:43:55Z | |
| Available date | 2021-11-09T13:43:55Z | |
| Document date | 2021 | |
| Citation | MATOS, Bruno Moisés de et al. Pluripotent‑derived mesenchymal stem/stromal cells: an overview of the derivation protocol efficacies and the differences among the derived cells. Stem Cell Reviews and Reports, p. 1–32, 2021. | pt_BR |
| ISSN | 1558-6804 | pt_BR |
| URI | https://www.arca.fiocruz.br/handle/icict/49742 | |
| Language | por | pt_BR |
| Publisher | Springer | pt_BR |
| Rights | restricted access | pt_BR |
| Title | Pluripotent‑derived mesenchymal stem/stromal cells: an overview of the derivation protocol efficacies and the differences among the derived cells | pt_BR |
| Type | Article | pt_BR |
| DOI | 10.1007/s12015-021-10258-z | |
| Abstract | Mesenchymal stem/stromal cells (MSCs) are remarkable tools for regenerative medicine. Therapeutic approaches using these cells can promote increased activity and viability in several cell types through diverse mechanisms such as paracrine and immunomodulatory activities, contributing substantially to tissue regeneration and functional recovery. However, biological samples of human MSCs, usually obtained from adult tissues, often exhibit variable behavior during in vitro culture, especially with respect to cell population heterogeneity, replicative senescence, and consequent loss of functionality. Accordingly, it is necessary to establish standard protocols to generate high-quality, stable cell cultures, for example, by using pluripotent stem cells (PSCs) in derivation protocols of MSC-like cells since PSCs maintain their characteristics consistently during culture. However, the available protocols seem to generate distinct populations of PSC-derivedMSCs (PSC-MSCs) with peculiar attributes, which do not always resemble bona fde primary MSCs. The present review addresses the developmental basis behind some of these derivation protocols, exposing the diferences among them and discussing the functional properties of PSC-MSCs, shedding light on elements that may help determine standard characterizations and criteria to evaluate and defne these cells. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Carlos Chagas. Curitiba, PR, Brasil. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Carlos Chagas. Curitiba, PR, Brasil. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Carlos Chagas. Curitiba, PR, Brasil. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Carlos Chagas. Curitiba, PR, Brasil / Universidade Federal do Paraná. Curitiba, PR, Brasil. | pt_BR |
| Subject | Mesenchymal Stem Cells | pt_BR |
| Subject | Pluripotent Stem Cells | pt_BR |
| Subject | Protocols | pt_BR |
| Subject | Therapeutics | pt_BR |
| Subject in Spanish | Células Madre Mesenquimatosas | pt_BR |
| Subject in Spanish | Células Madre Pluripotentes | pt_BR |
| Subject in Spanish | Terapéutica | pt_BR |
| Subject in French | Cellules souches mésenchymateuses | pt_BR |
| Subject in French | Cellules souches pluripotentes | pt_BR |
| Subject in French | Protocoles | pt_BR |
| Subject in French | Thérapeutique | pt_BR |
| DeCS | Células-Tronco Mesenquimais | pt_BR |
| DeCS | Células-Tronco Pluripotentes | pt_BR |
| DeCS | Protocolos | pt_BR |
| DeCS | Terapêutica | pt_BR |
